Health Reform Turbulence in the Trump Era: Market Impact and 2018 Outlook

Why Should You Attend:

Though the GOP majority succeeded in repealing the Affordable Care Act’s individual mandate as part of a massive tax bill enacted at the end of last year, the reality going forward is that what remains of the ACA is still functioning fairly well and ironically, leaves the government playing an even larger role under the health law than ever envisioned when passed by Congress in 2010. Looking ahead to 2018, expect Republican lawmakers and the Trump Administration to continue to push for reforms via a scattergun approach that utilizes legislation, rule making, executive actions, regulatory waivers and federal funding to further obstruct the ACA including repeal of ACA taxes and expand consumer choice for health insurance. This scenario will produce some discernible winners and losers among health plans and providers as the influence of public policy proposals and changes become more important in reshaping the larger healthcare system.

Areas Covered in the Webinar:

• Explain the market effect from repeal of the ACA individual mandate plus other administrative actions taken by the Trump Administration
• Assess new executive moves to dilute the ACA including rules to promote association health plans and short-term health insurance plans
• Interpret what’s behind the Administration’s sending mixed signals on value- based care initiatives
• Analyze the longer term anticipated market impact from recent legislative and administrative changes to the ACA
• Appraise how the dilution of the ACA will result in an larger overall government role under the health law
• Distinguish between the GOP House and Senate leadership reform initiatives in 2018 and the outlook for final actions this year
• Identify likely legislative dynamics surrounding Medicaid block grants and reauthorizing Medicare Extenders
• Understand how Medicare cuts to providers were averted during the beginning of 2018 and whether they can be avoided altogether throughout the year
• Discuss how political dynamics in 2018 including the midterm elections will affect the health reform debate
• Find out why the financial performance of health plans is being driven more by Medicare Advantage (MA) and Medicaid managed care than by the ACA
• Appraise the key takeaways by the push for market alliances including the proposed CVS-Aetna merger
• Describe three major 2018 health reform trends having the biggest market impact on providers and payers
• Identify who will be the biggest industry winners and losers in 2018 based on health reform market developments and trends

Who Will Benefit:

• CEO
• CFO
• COO
• CIO
• Hospital Administrator
• VP of medical affairs
• VP of planning & business development
• General counsel
• Administrative director

Dennis Weissman
President, Dennis Weissman and Associates LLC

Dennis Weissman is a nationally known independent analyst and thought leaders in the clinical laboratory and pathology sectors for over three decades. Dennis is president of Dennis Weissman & Associates, LLC of Falls Church, VA, a consultancy which provides market intelligence, M&A advisory services, public policy monitoring & advice and business leadership to diagnostic and life science companies and organizations. He has expertise in Medicare and health care reform policies and trends; clinical lab and pathology payment and compliance policies as well as M&A and business issues and direction to diagnostic and life science companies.

Dennis founded and served as publisher of Washington G-2 Reports (now G2 Intelligence) from 1979 through 1999, an information company that reports on and analyzes the U.S. clinical laboratory industry via newsletters, research reports; webinars and live conferences. Prior to G2, he served as Director of the Washington Office of the American Society for Medical Technology (now ASCLS) and before that, Special Assistant to the Deputy Assistance Secretary for Health, U.S. Department of Health, Education & Welfare (now HHS).

Follow us :